Some Targeted Therapy Drugs for Non–Small Cell Lung Cancer

Some Targeted Therapy Drugs for Non–Small Cell Lung Cancer

Target

Drug

NSCLC

ALK rearrangement

AlectinibAlectinib

BrigatinibBrigatinib

CeritinibCeritinib

CrizotinibCrizotinib

Adenocarcinoma

BRAF mutation

DabrafenibDabrafenib

Trametinib Trametinib

Adenocarcinoma

Squamous cell carcinoma

EGFR mutation

AfatinibAfatinib

ErlotinibErlotinib

GefitinibGefitinib

Necitumumab Necitumumab

Adenocarcinoma

Squamous cell carcinoma

EGFR (T790M mutation)

Osimertinib Osimertinib

Adenocarcinoma

Inhibit blood vessel growth

BevacizumabBevacizumab

Ramucirumab Ramucirumab

Adenocarcinoma

Immune activation (checkpoint inhibitors)

AtezolizumabAtezolizumab

CemiplimabCemiplimab

DurvalumabDurvalumab

IpilimumabIpilimumab

NivolumabNivolumab

PembrolizumabPembrolizumab

Adenocarcinoma

Squamous cell carcinoma

NSCLC = Non–small cell lung cancer.

NSCLC = Non–small cell lung cancer.

In these topics